The FDA has said it will expand unannounced inspections of overseas manufacturing facilities supplying medicine and other medical products to the US. The aim is to make sure that foreign companies ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a generative AI-based system for speeding up drug review - and plans to roll out ...

On May, 28, the FDA marked the tomato recall affecting three states as Class I, meaning there is a risk of "serious adverse health consequences or death." The tomato recall, initiated by ...